Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01028508 · ClinicalTrials.gov registry record · Phase 4
Prolonging Remission in Depressed Elderly (PRIDE)
A Phase 4 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 247
- Enrollment target
NCT01028508 is a Phase 4 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 247 participants.
The verdict
NCT01028508, a Phase 4 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 247 participants
- Enrollment target
Study Summary
This study will determine whether medications alone or medications and electroconvulsive therapy (ECT) work best to prevent depressive relapse and to improve quality of life for older people with severe mood disorders.
Interventions
- DRUG lithium and Venlafaxine
- PROCEDURE ECT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2010-01 |
| Est. Completion | 2016-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01028508
The ClinicalTrials.gov registry entry for NCT01028508 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 247 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lithium and Venlafaxine is the first listed.
NCT01028508 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01028508 about?
NCT01028508 is a clinical study titled "Prolonging Remission in Depressed Elderly (PRIDE)". This study will determine whether medications alone or medications and electroconvulsive therapy (ECT) work best to prevent depressive relapse and to improve quality of life for older people with severe mood disorders.
What is the current status of trial NCT01028508?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 247 participants. The study started on 2010-01. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01028508?
The interventions under investigation include: lithium and Venlafaxine (DRUG), ECT (PROCEDURE).
Who is sponsoring clinical trial NCT01028508?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.